Schedule 13G ownership disclosure
Spark Therapeutics, Inc.
Security class unavailable · CUSIP: 84652J103
Event date: 2018-03-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,780,420
- Percent of class
- 10.1600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-18-000441
- Form type
- SC 13G
- Filer
- Spark Therapeutics, Inc.
- CIK
- CIK 1609351
- Filed
- Apr 10, 2018
- Reporting period
- Mar 30, 2018
- Description
- Schedule 13G beneficial ownership